← ANALYSTS · TIPRANKS

James Condulis · Stifel Nicolaus

#3810among 12,504 TipRanks analysts★★★★★★★★★★
Hits 56% 22 of 39 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating +8.9% Over a year after the rating, TipRanks’ measure
Our companies rated now 10 Buy / hold / sell: 9 / 1 / 0
Upside of the analyst’s targets +134.7% Average over 10 current targets, to the last price
The market’s answer to the ratings +4.1% Day-0 move against SPY in the rating’s direction, average over 2 upgrades, downgrades and target changes
Date · added, NYStockAction RatingPrice target Upside Move vs SPY
Oct 14on TipRanks 16:25 MIRMIWMMirum Pharmaceuticals · $5.3B Reiterated Buy $136 → $156+14.7% +94.7% +2.8%next day −1.6%
Oct 1on TipRanks 10:15 AMLXIWMAmylyx Pharmaceuticals Inc · $3.4B Reiterated Buy $45.00 +70.8% −3.7%next day −1.8% · 5 days −4.4%
Oct 1on TipRanks 10:15 TECXIWMTectonic Therapeutic · $410M Reiterated Buy $75.00 +263.2% −2.8%next day −1.3% · 5 days −0.9%
Oct 1on TipRanks 10:15 BRVEBraveheart Bio, Inc. · $1.9B Reiterated Buy $45.00 +140.5% +5.8%next day −1.4% · 5 days −12.1%
Sep 30on TipRanks Sep 29 16:25 ACHVIWMAchieve Life Sciences · $717M Initiated Buy $18.00 +182.1% +5.4%next day −7.1% · 5 days −12.4%
Sep 8on TipRanks 06:50 NAMSNewAmsterdam Pharma Company · $2.4B Reiterated Buy $50.00 +152.1% +1.5%next day −10.6% · 5 days −16.3%
Aug 31on TipRanks 07:30 ARWRArrowhead Pharmaceuticals · $8.2B Reiterated Buy $104 +86.0% −2.7%next day +1.1% · 5 days +3.4%
Aug 11on TipRanks Aug 12 22:05 EWTXIWMEdgewise Therapeutics · $4.1B Reiterated Hold $36.00 −3.2% −0.3%next day −1.9% · 5 days 0.0%
Aug 7on TipRanks 08:15 CYTKIWMCytokinetics · $8.9B Reiterated Buy $108 +74.3% −6.3%next day +1.0% · 5 days −3.8%
Aug 7on TipRanks 08:15 XFORIWMX4 Pharmaceuticals · $262M Reiterated Buy $10.00 +286.1% +10.7%next day −8.4% · 5 days −9.5%

Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗